AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
231.80
+2.29 (1.00%)
At close: Nov 25, 2025, 4:00 PM EST
232.80
+1.00 (0.43%)
After-hours: Nov 25, 2025, 7:29 PM EST
AbbVie (ABBV) Operating Expense Breakdown
History
| Date | Selling, General, and Administrative | Acquired In-Process R&D | Research and Development | Other Expenses |
|---|---|---|---|---|
| Sep 30, 2025 | 13.97B | 5.33B | 13.29B | -62.00M |
| Jun 30, 2025 | 14.61B | 2.73B | 13.10B | -207.00M |
| Mar 31, 2025 | 14.73B | 2.84B | 12.92B | -352.00M |
| Dec 31, 2024 | 14.75B | 2.76B | 12.79B | -355.00M |
| Sep 30, 2024 | 14.09B | 1.47B | 7.94B | -358.00M |
| Jun 30, 2024 | 13.26B | 1.45B | 7.54B | -190.00M |
| Mar 31, 2024 | 13.15B | 792.00M | 7.32B | -22.00M |
| Dec 31, 2023 | 12.87B | 778.00M | 7.68B | 217.00M |
| Sep 30, 2023 | 13.10B | 739.00M | 7.54B | 456.00M |
| Jun 30, 2023 | 13.03B | 713.00M | 7.43B | 285.00M |
| Mar 31, 2023 | 15.17B | 702.00M | 7.31B | 114.00M |
| Dec 31, 2022 | 15.26B | 697.00M | 6.51B | 385.00M |
| Sep 30, 2022 | 15.10B | 859.00M | 6.55B | 656.00M |
| Jun 30, 2022 | 14.88B | 1.22B | 6.59B | 760.00M |
| Mar 31, 2022 | 12.63B | 1.08B | 6.75B | 864.00M |
| Dec 31, 2021 | 12.35B | 1.12B | 6.92B | -526.00M |
| Sep 30, 2021 | 12.32B | 1.02B | 6.99B | -1.92B |
| Jun 30, 2021 | 12.08B | 662.00M | 7.03B | -1.35B |
| Mar 31, 2021 | 12.45B | 1.38B | 6.85B | -780.00M |
| Dec 31, 2020 | 11.30B | 1.34B | 6.56B | - |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.